Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

945
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
945
Inflammation01:38

Inflammation

56.1K
Overview
56.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

63
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Inflammatory Response01:28

Inflammatory Response

11.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
11.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

257
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic risk score as a predictor of gestational diabetes in Central European Caucasians.

Scientific reports·2026
Same author

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Circulation·2026
Same author

Low Statin Doses Have No Effect on Plasma Concentrations of cfDNA or Muscle-Specific miRNA.

Folia biologica·2026
Same author

GLP-1 Receptor Agonists for Secondary Prevention After Myocardial Infarction and Stroke in Type 2 Diabetes: Nationwide Real-World Evidence.

European journal of preventive cardiology·2026
Same author

Changes in plasma concentration of cell-free DNA in response to physical activity.

Archives of medical science : AMS·2025
Same author

The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!

Global heart·2025

Related Experiment Video

Updated: Oct 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Statins and Inflammation.

Martin Satny1, Jaroslav A Hubacek2, Michal Vrablik3,4

  • 1First Faculty of Medicine, Charles Univesity, U Nemocnice 1, 128 08, Prague, Czech Republic.

Current Atherosclerosis Reports
|December 1, 2021
PubMed
Summary
This summary is machine-generated.

Statins reduce inflammation, a key factor in atherosclerosis. Their anti-inflammatory actions, independent of lipid-lowering, contribute significantly to their cardiovascular protective effects.

Keywords:
AtherosclerosisBiomarkersCardiovascularEndothelial functionInflammationPleiotropyStatins

More Related Videos

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Related Experiment Videos

Last Updated: Oct 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Pharmacology

Background:

  • Chronic inflammation is a primary driver in the development and progression of atherosclerosis.
  • Statins are highly effective in preventing and treating atherothrombotic vascular disease.
  • Emerging evidence highlights the critical role of inflammation in atherosclerosis pathogenesis.

Purpose of the Study:

  • To review the non-lipid-related, anti-inflammatory effects of statins.
  • To explore the significance of inflammation suppression in statin's therapeutic actions.
  • To discuss the vasculoprotective benefits derived from targeting inflammatory pathways.

Main Methods:

  • Review of experimental and clinical studies on statins and inflammation.
  • Analysis of clinical trial data, including selective anti-inflammatory agents like canakinumab.
  • Examination of cellular and molecular mechanisms underlying statin's anti-inflammatory properties.

Main Results:

  • Selective inhibition of interleukin 1-beta (canakinumab) demonstrated direct vasculoprotective effects.
  • Statins exhibit proven anti-inflammatory effects through both lipid-dependent and independent pathways.
  • These anti-inflammatory actions directly impact various cell types and inflammatory pathways.

Conclusions:

  • Inflammation is a critical therapeutic target in atherosclerosis.
  • The anti-inflammatory effects of statins are a crucial component of their atheroprotective action.
  • Statins offer significant vasculo- and atheroprotection beyond their lipid-lowering capabilities.